© 1998 by Oxford University Press
Journal of the National Cancer Institute, Vol. 90, No. 20, 1559-1563,
October 21, 1998
©Copyright 1998 Oxford University Press
REPORTS |
The Chondramides: Cytostatic Agents From Myxobacteria Acting on the Actin Cytoskeleton
Affiliation of authors: Abteilung Naturstoffbiologie, GBF, Gesellschaft für Biotechnologische Forschung mbH, Braunschwieg, Germany.
Correspondence to: Prof. Hans Reichenbach, GBF, Abteilung Naturstoffbiologie Mascheroder Weg 1, D-38124 Braunschweig, Germany.
Abstract
Background: Chondramides are cyclodepsipeptides produced by strains of the myxobacterium, Chondromyces crocatus. These peptides, which have been reported to inhibit yeast and mammalian cell proliferation, are related to jasplakinolide, which has been isolated from marine sponges of the genus Jaspis and has been shown to interfere with the actin cytoskeleton (a structural component of cells that helps maintain their shape and is involved in processes, such as cell division and cell locomotion). We studied the effects of the chondramides (A, B, C, and D) on tumor cell growth, on cytoskeletal structure, and on actin polymerization in vitro and compared these effects with those of cytochalasin D and jasplakinolide. Methods: Cell proliferation was measured by means of tetrazolium salt reduction assays. Effects on the cytoskeleton were studied by use of fluorescence techniques, and actin polymerization in vitro was measured by means of viscosimetry. Results: Proliferation of tested tumor cell lines was inhibited by the chondramides. Concentrations that inhibited proliferation by 50% (IC50 values) ranged from 3 to 85 nM and were of the same order of magnitude as those found for cytochalasin D and jasplakinolide. Fluorescence staining of potoroo cells incubated with chondramides A and B showed that organization of the actin cytoskeleton was disrupted; however, the microtubule system was not affected. Viscosimetric measurement showed that, depending on the experimental conditions, chondramide A induced or accelerated actin polymerization in vitro. Conclusion: The chondramides—unlike jasplakinolide—can be produced in large amounts by fermentation, and, similar to jasplakinolide, they appear to have antiproliferative activity against carcinoma cell lines by targeting the actin cytoskeleton. [J Natl Cancer Inst 1998;90:1559-63]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Rachid, D. Krug, K. J. Weissman, and R. Muller Biosynthesis of (R)-beta-Tyrosine and Its Incorporation into the Highly Cytotoxic Chondramides Produced by Chondromyces crocatus J. Biol. Chem., July 27, 2007; 282(30): 21810 - 21817. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Bai, D. G. Covell, C. Liu, A. K. Ghosh, and E. Hamel (-)-Doliculide, a New Macrocyclic Depsipeptide Enhancer of Actin Assembly J. Biol. Chem., August 23, 2002; 277(35): 32165 - 32171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bai, P. Verdier-Pinard, S. Gangwar, C. C. Stessman, K. J. McClure, E. A. Sausville, G. R. Pettit, R. B. Bates, and E. Hamel Dolastatin 11, a Marine Depsipeptide, Arrests Cells at Cytokinesis and Induces Hyperpolymerization of Purified Actin Mol. Pharmacol., March 1, 2001; 59(3): 462 - 469. [Abstract] [Full Text]
|
|